Avid Bioservices Inc (CDMO)

[Amrsto1000]

ADCT 8K equivalent issued yesterday.

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Source: Edgar (US Regulatory)

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2021.

 

Commission File Number: 001-39071

 

ADC Therapeutics SA

(Exact name of registrant as specified in its charter)

 

Biopôle

Route de la Corniche 3B

1066 Epalinges

Switzerland

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

?

 Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ?

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ?

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 ADC Therapeutics SADate: April 23, 2021    By:/s/ Michael Forer Name:Michael Forer Title:Executive Vice President & General Counsel



 

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.Description99.1Press release dated April 23, 2021